Stop Wasting Time And Start Xarelto Lawsuit
Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical firms, including the makers of Xarelto, possess a duty to ensure that their drugs are reasonably safe for use - and failure to complete so might be grounds for compensation. Our lawyers are working tough to have these hurt by the drug the compensation they are entitled to.
Whilst bleeding is actually a common complication related with anticoagulants, it has been alleged that Xarelto is more harmful than standard blood thinners simply because no antidote exists to reverse its blood-thinning effects. This implies that, within the occasion of an emergency, sufferers might be at danger for irreversible bleeding issues, including life-threatening internal and gastrointestinal hemorrhaging.
In the event you or perhaps a loved a single suffered a significant bleeding occasion following taking Xarelto, you may have legal recourse. For much more data, speak to us today to possess your case reviewed, cost-free of charge.
xarelto-compensation-photoThe plaintiffs in these lawsuits are searching for compensation from Bayer and Janssen for previous and future healthcare bills, lost wages, pain and suffering and, in cases of death, funeral expenses. Moreover, they're in search of punitive damages, which are generally awarded to punish the defendant and deter other businesses from acting similarly.
Why Are Lawsuits Getting Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Since of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding within the occasion of an emergency. Plaintiffs within the lawsuits allege serious and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a secure anticoagulant option.
Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.
Users of Xarelto Failure were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to critical bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.
Visit this page for far more information on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.